{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T21:34:57Z","timestamp":1782509697359,"version":"3.54.5"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004032","name":"Jilin University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004032","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.ejpb.2019.05.013","type":"journal-article","created":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T11:35:09Z","timestamp":1557833709000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Near-infrared light-responsive, pramipexole-loaded biodegradable PLGA microspheres for therapeutic use in Parkinson's disease"],"prefix":"10.1016","volume":"141","author":[{"given":"Shuang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijiang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesheng","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2019.05.013_b0005","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.neuropharm.2018.02.023","article-title":"Pramipexole and Fingolimod exert neuroprotection in a mouse model of Parkinson's disease by activation of sphingosine kinase 1 and Akt kinase","volume":"135","author":"Motyl","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejpb.2019.05.013_b0010","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejpb.2014.02.002","article-title":"Controlled iontophoretic delivery of pramipexole: electrotransport kinetics in vitro and in vivo","volume":"88","author":"Kalaria","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2019.05.013_b0015","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jphs.2018.08.008","article-title":"Neuroprotective effects of pramipexole transdermal patch in the MPTP-induced mouse model of Parkinson's disease","volume":"138","author":"Wang","year":"2018","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.ejpb.2019.05.013_b0020","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ejpb.2017.09.014","article-title":"Secretome released from hydrogel-embedded adipose mesenchymal stem cells protects against the Parkinson's disease related toxin 6-hydroxydopamine","volume":"121","author":"Chierchia","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2019.05.013_b0025","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ejpb.2018.02.031","article-title":"Simultaneous controlled iontophoretic delivery of pramipexole and rasagiline in vitro and in vivo: transdermal polypharmacy to treat Parkinson's disease","volume":"127","author":"Kalaria","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2019.05.013_b0030","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.neurobiolaging.2018.11.021","article-title":"Pramipexole-induced impulsivity in mildparkinsonian rats: a model of impulse control disorders in Parkinson's disease","volume":"75","author":"Urbieta","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ejpb.2019.05.013_b0035","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/mds.27372","article-title":"International Parkinson and movement disorder society evidence-based medicine review: update on treatments for the motor symptoms of Parkinson's disease","volume":"33","author":"Fox","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ejpb.2019.05.013_b0040","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijbiomac.2017.12.056","article-title":"Pramipexole dihydrochloride loaded chitosan nanoparticles for nose to brain delivery: development, characterization and in vivo anti-Parkinson activity","volume":"109","author":"Raj","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejpb.2019.05.013_b0045","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1177\/0269881117714051","article-title":"Striatal changes underlie MPEP-mediated suppression of the acquisition and expression of pramipexole-induced place preference in an alpha-synuclein rat model of Parkinson's disease","volume":"31","author":"Loiodice","year":"2017","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ejpb.2019.05.013_b0050","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1002\/adma.201002072","article-title":"Remotely triggerable drug delivery systems","volume":"22","author":"Timko","year":"2010","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ejpb.2019.05.013_b0055","first-page":"15","article-title":"Engineered photo-responsive materials for near-infrared-triggered drug delivery","volume":"31","author":"Cho","year":"2015","journal-title":"J. Ind. Eng."},{"key":"10.1016\/j.ejpb.2019.05.013_b0060","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.drudis.2018.02.005","article-title":"Recent advances in near-infrared light-responsive nanocarriers for cancer therapy","volume":"23","author":"Saneja","year":"2018","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejpb.2019.05.013_b0065","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201702299","article-title":"Recent progress in near infrared light triggered photodynamic therapy","volume":"13","author":"Deng","year":"2017","journal-title":"Small"},{"key":"10.1016\/j.ejpb.2019.05.013_b0070","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ccr.2016.01.014","article-title":"Unique optical properties and applications of hollow gold nanospheres (HGNs)","volume":"320\u2013321","author":"Adams","year":"2016","journal-title":"Coordination Chem. Rev."},{"key":"10.1016\/j.ejpb.2019.05.013_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/534070","article-title":"Preparation, modification, and application of hollow gold nanospheres","volume":"2015","author":"Ren","year":"2015","journal-title":"J. Nanomater."},{"key":"10.1016\/j.ejpb.2019.05.013_b0080","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2147\/IJN.S121948","article-title":"Disulfiram-loaded porous PLGA microparticle for inhibiting the proliferation and migration of non-small-cell lung cancer","volume":"12","author":"Chen","year":"2017","journal-title":"Int. J. Nanomed."},{"issue":"6","key":"10.1016\/j.ejpb.2019.05.013_b0085","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3109\/10837451003739297","article-title":"Biodegradable poly(D, L-lactide-co-glycolide) (PLGA) microspheres for sustained release of risperidone: Zero-order release formulation","volume":"1","author":"Su","year":"2011","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ejpb.2019.05.013_b0090","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/smll.201000028","article-title":"Near-infrared light triggers release of Paclitaxel from biodegradable microspheres: photothermal effect and enhanced antitumor activity","volume":"6","author":"You","year":"2010","journal-title":"Small"},{"key":"10.1016\/j.ejpb.2019.05.013_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ppsc.201600255","article-title":"Size-tunable synthesis of hollow gold nanospheres through control of reaction temperature","volume":"34","author":"Pu","year":"2017","journal-title":"Part. Part. Syst. Char."},{"key":"10.1016\/j.ejpb.2019.05.013_b0100","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1039\/C0JM03690K","article-title":"Highly reproducible synthesis of hollow gold nanospheres with near infrared surface plasmon absorption using PVP as stabilizing agent","volume":"21","author":"Sandra","year":"2011","journal-title":"J. Mater. Chem."},{"key":"10.1016\/j.ejpb.2019.05.013_b0105","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0378-4347(96)00123-5","article-title":"Determination of pramipexole (U-98,528) in human plasma and urine by high-performance liquid chromatography with electrochemical and ultraviolet detection","volume":"683","author":"Lau","year":"1996","journal-title":"J. Chromatography B."},{"key":"10.1016\/j.ejpb.2019.05.013_b0110","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00702-019-01970-9","article-title":"Mesencephalic and extramesencephalic dopaminergic systems in Parkinson's disease","volume":"126","author":"Geibl","year":"2019","journal-title":"J. Neural. Transm. (Vienna)"},{"key":"10.1016\/j.ejpb.2019.05.013_b0115","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00702-018-1903-3","article-title":"Human tyrosine hydroxylase in Parkinson's disease and in related disorders","volume":"126","author":"Nagatsu","year":"2019","journal-title":"J. Neural. Transm. (Vienna)"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641119300578?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641119300578?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:33:00Z","timestamp":1760545980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641119300578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":23,"alternative-id":["S0939641119300578"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2019.05.013","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Near-infrared light-responsive, pramipexole-loaded biodegradable PLGA microspheres for therapeutic use in Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2019.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}